vs

Side-by-side financial comparison of First Bancorp, Inc (FNLC) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $25.8M, roughly 1.9× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs -71.6%, a 110.9% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -11.8%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-24.9M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -11.9%).

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

FNLC vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.9× larger
MRVI
$49.9M
$25.8M
FNLC
Growing faster (revenue YoY)
FNLC
FNLC
+29.4% gap
FNLC
17.5%
-11.8%
MRVI
Higher net margin
FNLC
FNLC
110.9% more per $
FNLC
39.4%
-71.6%
MRVI
More free cash flow
FNLC
FNLC
$59.5M more FCF
FNLC
$34.6M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
FNLC
FNLC
Annualised
FNLC
18.1%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FNLC
FNLC
MRVI
MRVI
Revenue
$25.8M
$49.9M
Net Profit
$10.2M
$-35.7M
Gross Margin
25.8%
Operating Margin
48.1%
-117.9%
Net Margin
39.4%
-71.6%
Revenue YoY
17.5%
-11.8%
Net Profit YoY
39.7%
-37.7%
EPS (diluted)
$0.91
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNLC
FNLC
MRVI
MRVI
Q4 25
$25.8M
$49.9M
Q3 25
$24.5M
$41.6M
Q2 25
$22.5M
$47.4M
Q1 25
$21.8M
$46.9M
Q4 24
$22.0M
$56.6M
Q3 24
$20.5M
$69.0M
Q2 24
$19.2M
$69.4M
Q1 24
$18.5M
$64.2M
Net Profit
FNLC
FNLC
MRVI
MRVI
Q4 25
$10.2M
$-35.7M
Q3 25
$9.1M
$-25.6M
Q2 25
$8.1M
$-39.6M
Q1 25
$7.1M
$-29.9M
Q4 24
$7.3M
$-25.9M
Q3 24
$7.6M
$-97.1M
Q2 24
$6.2M
$-9.8M
Q1 24
$6.0M
$-12.1M
Gross Margin
FNLC
FNLC
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
FNLC
FNLC
MRVI
MRVI
Q4 25
48.1%
-117.9%
Q3 25
45.2%
-98.6%
Q2 25
43.7%
-139.8%
Q1 25
39.3%
-104.9%
Q4 24
39.5%
-66.7%
Q3 24
44.6%
-239.9%
Q2 24
38.8%
-19.4%
Q1 24
39.3%
-29.4%
Net Margin
FNLC
FNLC
MRVI
MRVI
Q4 25
39.4%
-71.6%
Q3 25
37.0%
-61.4%
Q2 25
35.8%
-83.5%
Q1 25
32.5%
-63.9%
Q4 24
33.1%
-45.8%
Q3 24
36.9%
-140.6%
Q2 24
32.1%
-14.1%
Q1 24
32.5%
-18.8%
EPS (diluted)
FNLC
FNLC
MRVI
MRVI
Q4 25
$0.91
$-0.24
Q3 25
$0.81
$-0.18
Q2 25
$0.72
$-0.27
Q1 25
$0.63
$-0.21
Q4 24
$0.66
$-0.21
Q3 24
$0.68
$-0.68
Q2 24
$0.55
$-0.07
Q1 24
$0.54
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNLC
FNLC
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$95.5M
$291.8M
Stockholders' EquityBook value
$283.1M
$212.4M
Total Assets
$3.2B
$770.6M
Debt / EquityLower = less leverage
0.34×
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNLC
FNLC
MRVI
MRVI
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
FNLC
FNLC
MRVI
MRVI
Q4 25
$95.5M
$291.8M
Q3 25
$95.5M
$292.8M
Q2 25
$95.0M
$293.9M
Q1 25
$70.0M
$294.9M
Q4 24
$95.0M
$295.9M
Q3 24
$95.0M
$521.7M
Q2 24
$70.0M
$522.5M
Q1 24
$70.0M
$523.3M
Stockholders' Equity
FNLC
FNLC
MRVI
MRVI
Q4 25
$283.1M
$212.4M
Q3 25
$274.6M
$245.4M
Q2 25
$265.5M
$265.9M
Q1 25
$259.7M
$300.6M
Q4 24
$252.5M
$325.3M
Q3 24
$256.8M
$344.9M
Q2 24
$244.7M
$434.7M
Q1 24
$242.6M
$410.7M
Total Assets
FNLC
FNLC
MRVI
MRVI
Q4 25
$3.2B
$770.6M
Q3 25
$3.2B
$849.2M
Q2 25
$3.2B
$897.0M
Q1 25
$3.2B
$959.8M
Q4 24
$3.2B
$1.0B
Q3 24
$3.1B
$1.3B
Q2 24
$3.1B
$1.4B
Q1 24
$3.0B
$1.4B
Debt / Equity
FNLC
FNLC
MRVI
MRVI
Q4 25
0.34×
1.37×
Q3 25
0.35×
1.19×
Q2 25
0.36×
1.11×
Q1 25
0.27×
0.98×
Q4 24
0.38×
0.91×
Q3 24
0.37×
1.51×
Q2 24
0.29×
1.20×
Q1 24
0.29×
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNLC
FNLC
MRVI
MRVI
Operating Cash FlowLast quarter
$37.8M
$-22.8M
Free Cash FlowOCF − Capex
$34.6M
$-24.9M
FCF MarginFCF / Revenue
133.9%
-49.9%
Capex IntensityCapex / Revenue
12.5%
4.2%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$55.3M
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNLC
FNLC
MRVI
MRVI
Q4 25
$37.8M
$-22.8M
Q3 25
$12.9M
$-15.2M
Q2 25
$7.4M
$-10.3M
Q1 25
$2.2M
$-9.4M
Q4 24
$26.0M
$-14.6M
Q3 24
$9.8M
$13.1M
Q2 24
$6.4M
$17.4M
Q1 24
$-1.5M
$-8.5M
Free Cash Flow
FNLC
FNLC
MRVI
MRVI
Q4 25
$34.6M
$-24.9M
Q3 25
$12.6M
$-18.1M
Q2 25
$7.2M
$-13.1M
Q1 25
$828.0K
$-14.6M
Q4 24
$24.6M
$-20.5M
Q3 24
$9.6M
$4.5M
Q2 24
$6.3M
$7.9M
Q1 24
$-1.8M
$-14.1M
FCF Margin
FNLC
FNLC
MRVI
MRVI
Q4 25
133.9%
-49.9%
Q3 25
51.4%
-43.4%
Q2 25
32.1%
-27.7%
Q1 25
3.8%
-31.2%
Q4 24
111.7%
-36.2%
Q3 24
47.0%
6.6%
Q2 24
32.9%
11.4%
Q1 24
-9.8%
-22.0%
Capex Intensity
FNLC
FNLC
MRVI
MRVI
Q4 25
12.5%
4.2%
Q3 25
1.2%
7.0%
Q2 25
0.6%
6.1%
Q1 25
6.2%
11.2%
Q4 24
6.7%
10.3%
Q3 24
0.5%
12.4%
Q2 24
0.3%
13.8%
Q1 24
1.8%
8.8%
Cash Conversion
FNLC
FNLC
MRVI
MRVI
Q4 25
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FNLC
FNLC

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons